Synthetic Sansanmycin Analogues as Potent Mycobacterium tuberculosis Translocase I Inhibitors

Author:

Tran Wendy1,Kusay Ali S.23ORCID,Hawkins Paige M. E.1ORCID,Cheung Chen-Yi4,Nagalingam Gayathri5,Pujari Venugopal6,Ford Daniel J.1,Stoye Alexander1,Ochoa Jessica L.7ORCID,Audette Rebecca E.8,Hortle Elinor5,Oehlers Stefan H.5,Charman Susan A.9ORCID,Linington Roger G.10ORCID,Rubin Eric J.8,Dowson Christopher G.11ORCID,Roper David I.11ORCID,Crick Dean C.6ORCID,Balle Thomas23,Cook Gregory M.4,Britton Warwick J.5,Payne Richard J.112ORCID

Affiliation:

1. School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia

2. Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia

3. Brain and Mind Centre, The University of Sydney, Camperdown, NSW 2050, Australia

4. Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand

5. Centenary Institute and Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia

6. Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523, United States

7. Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, United States

8. Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts 02115, United States

9. Centre for Drug Candidate Optimisation, Monash University, Parkville, VIC 3052, Australia

10. Department of Chemistry, Simon Fraser University, Burnaby, BC V5A 1S6, Canada

11. School of Life Sciences, University of Warwick, Coventry CV4 7AL, U.K.

12. Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, NSW 2006, Australia

Funder

National Health and Medical Research Council

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference48 articles.

1. WHO, Global Tuberculosis Report 2021; World Health Organization: Geneva, Switzerland, 2021.

2. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

3. WHO, Global Tuberculosis Report 2019; World Health Organization: Geneva, Switzerland, 2019.

4. WHO, The top 10 causes of death. 2018.

5. Accelerating progress towards tuberculosis elimination: the need for combination treatment and prevention

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3